drugset / Trial / NCT01288079
A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the safety and effect of TC-5214 as a single therapy in patients with major depressive disorder who exhibit inadequate response to antidepressants.
Timeline
- Start
- 2011-02
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Duloxetine | Small molecule | 60 mg | Oral |
| Subject | dexmecamylamine | Other / unclassified | 1 mg | Oral |
| Subject | dexmecamylamine | Other / unclassified | 4 mg | Oral |